Mepenzolate

Back to search

Molecule Structure

Scientific Name

Mepenzolate

Description of the Drug

Mepenzolate is a postganglionic parasympathetic inhibitor that was previously approved for improving the healing of gastric ulcers, but has been discontinued.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04843

Brand Name(s)

Not Available

Company Owner(s)

Sanofi Aventis Us Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Muscarinic acetylcholine receptor M1 SINGLE PROTEIN ANTAGONIST CHEMBL216
Muscarinic acetylcholine receptor M3 SINGLE PROTEIN ANTAGONIST CHEMBL245

Unichem Links

SureChEMBL SCHEMBL2994933
PharmGKB PA164746250
Human Metabolome Database HMDB0015591
DrugBank DB04843
PubChem 4057
LINCS LSM-5102
Nikkaji J21.250D
BindingDB 50377964
EPA CompTox Dashboard DTXSID2046969
DrugCentral 1689
Guide to Pharmacology 10470
rxnorm MEPENZOLATE BROMIDE MEPENZOLATE
ChEBI 94411